Performance assessment of microflow LC combined with high-resolution MS in bioanalysis

Bioanalysis

Volumn 5, Issue 10, 2013, Pages 1249-1267

  Wang, Hongxia ^a   Bennett, Patrick ^a  

^a Thermo Fisher Scientific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BUSPIRONE; CLOPIDOGREL; TERFENADINE;

ACCURACY; ARTICLE; BIOASSAY; CONTROLLED STUDY; FLOW RATE; HUMAN; INTERMETHOD COMPARISON; ION MONITORING; IONIZATION; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

ALPRAZOLAM; BIOLOGICAL MARKERS; BLOOD PROTEINS; BUSPIRONE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; PROTEOMICS; TANDEM MASS SPECTROMETRY; TERFENADINE; TICLOPIDINE;

EID: 84878490206     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.93     Document Type: Article

References (35)

1. Baranowska I, Magiera S, Baranowski J. Clinical applications of fast liquid chromatography: a review on the ana lysis of cardiovascular drugs and their metabolites. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. doi:10.1016/j. jchromb.02.002 (Epub ahead of print) (2013).
2. Nováková L, Vlcková H. A review of current trends and advances in modern bio-analytical methods: chromatography and sample preparation. Anal. Chim. Acta 656(1-2), 8-35 (2009).
3. Makarov A, Scigelova M. Coupling liquid chromatography to Orbitrap mass spectrometry. J. Chromatogr. A 1217(25), 3938-3945 (2010).
4. Valaskovic GA, Utley L, Lee MS, Wu JT. Ultra-low fow nanospray for the normalization of conventional liquid chromatography/mass spectrometry through equimolar response: standard-free quantitative estimation of metabolite levels in drug discovery. Rapid Commun. Mass Spectrom. 20(7), 1087-1096 (2006).
5. Chelius D, Zhang T, Wang GH, Shen RF. Global protein identifcation and quantifcation technology using two dimensional liquid chromatography nanospray mass spectrometry. Anal. Chem. 75 (23), 6658-6665(2003).
6. Hall TG, Smukste I, Bresciano KR, Wang YX, McKearn D, Savage RE. Chapter 19. Identifying and overcoming matrix effects in drug discovery and development. In: Tandem Mass Spectrometry-Applications and Principles. Prasain J (Ed.). ArQule Inc., MA, USA, 389-420 (2012).
7. Gangl ET, Annan MM, Spooner N, Vouros P. Reduction of signal suppression effects in ESI-MS using a nanosplitting device. Anal. Chem. 73(23), 5635-5644 (2002).
8. Percy AJ, Chambers AG, Yang J, Domanski D, Borchers CH. Comparison of standard-and nano-fow liquid chromatography platforms for MRM-based quantitation of putative plasma biomarker proteins. Anal. Bioanal. Chem. 404(4), 1089-1101 (2012).
9. Chen J, Yang L, Kapron JT et al. Determination of SCH 211803 by nanoelectrospray infusion mass spectrometry: evaluation of matrix effect and comparison with liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 809(2), 205-210 (2004).
10. He X, Kozak M, Nimkar S. Ultra-sensitive measurements of 11-Nor-d (9) tetrahydrocannabinol-9-carboxylic acid in oral fuid by microfow liquid chromatography-tandem mass spectrometry using a benchtop quadrupole/orbitrap mass spectrometer. Anal. Chem. 84(18), 7643-7647 (2012).
11. Hatsis P, Brockman AH, Wu JT. Evaluation of high-feld asymmetric waveform ion mobility spectrometry coupled to nanoelectrospray ionization for bioana lysis in drug discovery. Rapid Commun. Mass Spectrom. 21(14), 2295-2300 (2007).
12. Chambers E, Wagnowski-Diehl DM, Lu ZL, Mazzeo JR. Systematic and comprehensive strategy for reducing matrix effects in LC-MS/MS ana lysis. J. Chromatogr. B 852(1-2), 22-34 (2007).
13. Little J, Wempe M, Buchanan C. Liquid chromatography-mass spectrometry/mass spectrometry method development for drug metabolism studies: examining lipid matrix ionization effects in plasma. J. Chromatogr. B 833(2), 219-230 (2006).
14. Bennett P, Meng M. Source for imprecision resulting from ionization suppression from strongly retained phospholipids and dioctyl phthalate. Presented at: 52th ASMS Conference on Mass Spectrometry and Allied Topics. Nashville, TN, USA, 23-27 May 2004.
15. Bennett P, Van Horne C. Identifcation of the major endogenous and persistent compounds in plasma, serum, and tissue that cause matrix effects with electrospray LC/MS techniques. Presented at: AAPS Annual Meeting and Exposition. Salt Lake City, UT, USA, 26-30 October 2003.
16. Mei H, Hsieh Y, Nardo C et al. Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: Application to drug discovery. Rapid Commun. Mass Spectrom 17, 97-103 (2003).
17. Jemal M, Ouyang Z, Yuan-Qing X. Systematic LC-MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought-out chromatography. Biomed. Chromatogr. 24, 2-19 (2010).
18. Beck A, Wagner-Rousset E, Ayoub D, Van Dorsselaer A, Sanglier- Cianférani S. Characterization of therapeutic antibodies and related products. Anal. Chem. 85(2), 715-736 (2013).
19. Schadt S, Chen LZ, Bischoff D. Evaluation of relative LC/MS response of metabolites to parent drug in LC/nanospray ionization mass spectrometry: potential implications in MIST assessment. J. Mass Spectrom. 46(12), 1281-1286 (2011).
20. Ruan Q, Ji QC, Arnold ME, Humphreys GW, Zhu MS. Strategy and its implications of protein bioana lysis utilizing high-resolution mass spectrometric detection of intact protein. Anal. Chem. 83(23), 8937-8944 (2011).
21. Peterson AC, Russell JD, Bailey DJ, Westphall MS, Coon JJ. Parallel reaction monitoring for high-resolution and high mass accuracy quantitative, targeted proteomics. Mol. Cell. Proteomics 11(11), 1475-1488(2012).
22. Gallien S, Duriez E, Demeure K, Domon B. Selectivity of LC-MS/MS ana lysis: implication for proteomics experiments. J. Proteomics 81, 148-158 (2013).
23. Fung EN, Xia YQ, Aubry AF, Zeng J, Olah T, Jemal M. Full-scan high-resolution accurate mass spectrometry (HRMS) in regulated bioana lysis: LC-HRMS for the quantitation of prednisone and prednisolone in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(27), 2919-2927(2011).
24. Kaufmann A, Butcher P, Maden K, Walker S, Widmer M. Comprehensive comparison of liquid chromatography selectivity as provided by two types of liquid chromatography detectors (high-resolution mass spectrometry and tandem mass spectrometry): 'Where is the crossover point?' Anal. Chim. Acta, 700(1-2), 86-94 (2011).
25. Xia YQ, Lau J, Olah T, Jemal M. Targeted quantitative bioana lysis in plasma using liquid chromatography/high-resolution accurate mass spectrometry: an evaluation of global selectivity as a function of mass resolving power and extraction window, with comparison of centroid and profle modes. Rapid Commun. Mass Spectrom. 25, 2863-2878 (2011).
26. Bateman K P, Kellmann M, Muenster H, Papp R, Taylor L. Quantitative-qualitative data acquisition using a benchtop Orbitrap mass spectrometer. J. Am. Soc. Mass Spectrom. 20(8), 1441-1450 (2009).
27. Pinhancos R, Maass S, Ramanathan DM. High-resolution mass spectrometry method for the detection, characterization and quantitation of pharmaceuticals in water. J. Mass Spectrom. 46 (11), 1175-1181 (2011).
28. Dolan JW. The role of the signal-to-noise ratio in precision and accuracy. LCGC North America 23(12), 1256 (2005).
29. Matuszewski BK, Constanzer ML, Chavez-Eng CM. A systematic approach to reducing matrix effects in LC-MS/MS analyses. Anal. Chem. 75, 3019-3030 (2003).
30. Shen JX, Motyka RJ, Roach JP, Hayes RN. Minimization of ion suppression in LC-MS/MS ana lysis through the application of strong cation exchange solid-phase extraction (SCX-SPE). J. Pharm. Biomed. Anal. 37, 359-367 (2005).
31. Du L, White RL. Reducing glycerophosphocholine lipid matrix interference effects in biological fuid assays by using high-turbulance liquid chromatography. Rapid Commun. Mass Spectrom. 22, 3362-3370 (2008).
32. Liang HR, Foltz RL, Meng M, Bennett P. Ionization enhancement in atmospheric pressure chemical ionization and suppression in electrospray ionization between target drugs and stable-isotope-labeled internal standards in quantitative liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 17, 2815-2821 (2003).
33. Shou WZ, Naidong W. Post-column infusion study of the 'dosing vehicle effect' in the liquid chromatography/tandem mass spectrometric ana lysis of discovery pharmacokinetic samples. Rapid Commun. Mass Spectrom. 17, 589-597 (2003).
34. Xu X, Mei H, Wang S et al. A study of common discovery dosing formulation components and their potential for causing time-dependent matrix effects in high-performance liquid chromatography tandem mass spectrometry assays. Rapid Commun. Mass Spectrom. 19(18), 2643-2650 (2005).
35. Bonfglio R, King RC, Olah T V, Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun. Mass Spectrom. 13(12), 1175-1185 (1999).